Polycystic Ovarian Syndrome (PCOS) is a prevalent endocrine disorder that significantly affects women’s health, but its impact on women remains overlooked. In this study, various metabolic and hematologic tests were performed, with the aims: (1) determine test results of metabolic parameters: (a) fasting blood sugar (FBS), (b) total cholesterol, (c) blood urea nitrogen (BUN), & (d) creatinine; and (2) hematologic parameters: (e) hematocrit (Hct), (f) hemoglobin (Hb), (g) prothrombin time (PT), & (h) activated partial thromboplastin time (aPTT) among PCOS-diagnosed women. As well as to (3) determine the significant relationship between the date of PCOS diagnosis with the metabolic and hematologic parameters. The group consists of 10 PCOS-diagnosed women Ten (10), 18-35-year old women, medically diagnosed with PCOS by a physician in City of San Fernando, La Union. Statistical analysis revealed that the mean total cholesterol of the respondents are interpreted as “high” and are therefore more likely to exhibit abnormally elevated total cholesterol levels more than FBS, BUN and creatinine. They are also more likely to exhibit normal hematologic parameters, such as Hct, Hb, PT, and aPTT. It was also pointed out that there is no significant relationship between the date of diagnosis of PCOS and the metabolic and hematologic parameters in PCOS-diagnosed women. Thus, regardless of the time of diagnosis of PCOS, it does not actually affect their metabolic and hematologic manifestations. This study posits that PCOS-diagnosed women are likely to have affected metabolic functions more than hematologic functions.
